Clinical Trials on Metastatic Well Differentiated Neuroendocrine Neoplasm
Total 36319 results
-
BayerTerminated
-
University of PennsylvaniaAbramson Cancer Center of the University of PennsylvaniaNo longer availableMetastatic CancerUnited States
-
Northwestern UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMetastatic CancerUnited States
-
European Organisation for Research and Treatment...TerminatedMetastatic CancerFrance, Finland, United Kingdom, Belgium, Israel, Germany, Switzerland, Netherlands, Turkey, Italy, Portugal, Spain, Latvia
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma | Metastatic MelanomaUnited States
-
Fudan UniversityNot yet recruitingPancreatic Neuroendocrine NeoplasmChina
-
Apexigen America, Inc.Bristol-Myers SquibbCompletedMelanoma | Cancer | Metastatic Melanoma | Non Small Cell Lung Cancer Metastatic | Neoplasm of LungUnited States, Spain
-
Jiangxi Provincial Cancer HospitalRecruitingMetastatic CancerChina
-
Gustave Roussy, Cancer Campus, Grand ParisRoche Pharma AGRecruiting
-
Lawson Health Research InstituteVU University of Amsterdam; London Regional Cancer Program, CanadaActive, not recruitingMetastatic TumorsCanada, Australia, Netherlands, United Kingdom
-
Milton S. Hershey Medical CenterCompleted
-
Hoffmann-La RocheCompletedNeoplasmsUnited States, France, Spain, Korea, Republic of, United Kingdom
-
Alliance Foundation Trials, LLC.Patient-Centered Outcomes Research Institute; Mayo Clinic; Dana-Farber Cancer... and other collaboratorsActive, not recruitingMetastatic CancerUnited States
-
National Institutes of Health Clinical Center (CC)No longer available
-
Jonsson Comprehensive Cancer CenterCompleted
-
Eli Lilly and CompanyCompleted
-
Viatar LLCUnknown
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic DiseaseUnited States
-
Eli Lilly and CompanyCompleted
-
Leiden University Medical CenterPierre Fabre LaboratoriesRecruitingMelanoma Stage III | In-Transit Metastasis of Cutaneous MelanomaNetherlands
-
Sunnybrook Health Sciences CentreActive, not recruiting
-
AkesoNot yet recruitingMetastasis | Advanced or Metastatic Solid Tumors | MalignancyAustralia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Unresectable Adrenal Gland Pheochromocytoma | Unresectable Paraganglioma | Regional Adrenal Gland PheochromocytomaUnited States
-
National Cancer Institute (NCI)CompletedMelanoma | Neoplasm MetastasisUnited States
-
Hoffmann-La RocheCompletedMetastatic CancersSpain
-
Genentech, Inc.CompletedMetastatic Melanoma, BRAF V600 Mutation PositiveKorea, Republic of, Russian Federation, Israel, United States
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
VicalCompletedMetastatic MelanomaUnited States, Belgium, Brazil, Canada, France, Germany, Israel, Italy, Netherlands, Poland, Russian Federation, Spain, Switzerland, Turkey
-
M.D. Anderson Cancer CenterCortice Biosciences, Inc.Withdrawn
-
Nantes University HospitalNot yet recruiting
-
University Hospital, BrestRecruitingPET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy (IMMUNOPET2)Metastatic MelanomaFrance
-
Regeneron PharmaceuticalsBristol-Myers SquibbCompletedMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Regeneron PharmaceuticalsBristol-Myers SquibbActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
PfizerCompletedBRAF or NRAS Mutant Metastatic MelanomaUnited States, Netherlands, Italy, Germany, Switzerland
-
University Hospital TuebingenTerminatedMetastatic Melanoma (Carrying BRAF V600 Mutation)Germany
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
Jonsson Comprehensive Cancer CenterPfizer; Schering-PloughCompletedTemozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaMetastatic MelanomaUnited States
-
International Group of Endovascular OncologyUnknownMetastatic MelanomaItaly
-
Infinity Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
CelgeneICON Clinical ResearchCompletedMelanoma | Neoplasm MetastasisAustralia, United Kingdom, Ukraine, Germany, Estonia, Latvia, Lithuania, Netherlands, South Africa
-
Rockefeller UniversityCompletedMelanoma | Neoplasm MetastasisUnited States
-
Baylor Research InstituteMary Crowley Medical Research Center; ODC TherapyCompletedMelanoma | Neoplasm MetastasisUnited States
-
National Cancer Institute (NCI)CompletedMelanoma | Neoplasm MetastasisUnited States
-
Celgene CorporationCompletedMelanoma | Neoplasm MetastasisUnited States, Canada
-
Soonchunhyang University HospitalSMG-SNU Boramae Medical CenterNot yet recruitingNeoplasms | Secondary Malignant Neoplasm
-
St. Louis UniversityCompletedMelanoma | Metastatic Melanoma | Stage IV Melanoma | Unresectable Malignant Neoplasm | Stage III MelanomaUnited States
-
FDA Office of Orphan Products DevelopmentCompleted
-
University of WashingtonSteven & Alexandra Cohen FoundationActive, not recruitingMetastatic Malignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Suzhou Transcenta Therapeutics Co., Ltd.RecruitingColorectal Adenocarcinoma | Locally Advanced Solid Tumor | Metastatic TumorUnited States
-
Karolinska University HospitalRecruitingMetastatic MelanomaSweden